Navigation Links
FDA Approves Opioid Analgesic to Help Cancer Patients Manage Pain
Date:1/7/2011

SILVER SPRING, Md., Jan. 7, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Abstral (fentanyl) transmucosal tablets to manage breakthrough pain for adults with cancer.  Fentanyl immediate-release transmucosal medications are administered on the soft surfaces of the mouth (inside of the cheek, gums, tongue), or the nasal passages or throat where they dissolve and are absorbed.

(Logo:  http://photos.prnewswire.com/prnh/20090824/FDALOGO)

"This is an important step for patients with cancer pain to have options for the treatment of their breakthrough pain," said John Jenkins, M.D., director of FDA's Office of New Drugs in the Center for Drug Evaluation and Research.

Abstral is indicated for the management of breakthrough pain in patients with cancer, ages 18 years and older, who already use opioid pain medication around the clock and who need and are able to safely use high doses of an additional opioid medicine.  Breakthrough pain is pain that comes on suddenly for short periods of time and is not alleviated by a patient's normal pain management plan. These patients are considered opioid tolerant because of their current opioid medication use.  Only health care professionals skilled in the use of Schedule II opioids to treat pain should prescribe this drug product.  

Abstral is available only through a Risk Evaluation and Mitigation Strategy (REMS) program, which is intended to minimize the risk of misuse, abuse, addiction and overdose.  Under this program, pharmacies, distributors, and health care professionals who prescribe to outpatients are required to enroll in the program to prescribe, dispense and distribute this product.  FDA has standardized key components of the REMS program to facilitate the adoption of a single shared system. These components include the REMS document, th
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. VIDEO from Endo Pharmaceuticals Available on thenewsmarket.com: FDA Approves New Treatment for Low Testosterone
2. FDA Approves New Dosage Strength for INTELENCE®
3. U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels
4. FDA Approves PREZISTA®/ritonavir Once-Daily Dosing for HIV-1 Treatment-Experienced Adults With No Darunavir Resistance-Associated Mutations
5. FDA Approves New Manufacturing Facility for Collagenase SANTYL® Ointment
6. Vermillion Reappoints Three Directors, Approves a New Stock Incentive Plan, and Ratifies PricewaterhouseCoopers LLP as Its Accounting Firm
7. FDA Approves Xgeva to Help Prevent Cancer-Related Bone Injury
8. FDA Approves New Treatment Option for Late-Stage Breast Cancer
9. FDA Approves Vyvanse® (lisdexamfetamine dimesylate) Capsules CII for the Treatment of ADHD in Adolescents
10. FDA Approves Cymbalta® for the Management of Chronic Musculoskeletal Pain
11. FDA Approves New Indication for Afinitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , January 15, 2014 Shire plc (LSE: SHP, ... Office of Fair Trading (OFT) approval condition to the announced tender ... VPHM).   As a result of the waiver, the ... to complete the tender offer on January 24, 2014 following the ...
(Date:1/15/2014)... BEACH GARDENS, Fla. , Jan. 15, 2014  In an unprecedented ... difficile and TB in ambulances and other transport vehicles, an advanced ... used by rescue personnel for the first time. ... in contact with these deadly pathogens, West Palm Beach ...
(Date:1/15/2014)... The Cadence Fitness & Health Center has been ... Fitness Association, a non-profit organization assisting medically integrated health ... Cadence Fitness & Health Center is the only certified ... the Chicagoland area. "The certification means the ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... , Findings Published in Nature Medicine Suggest Broad Implications ... , SOUTH SAN FRANCISCO, Calif., June 15 ... in Nature Medicine, Proteolix,s selective immunoproteasome inhibitor ... models of rheumatoid arthritis in a dose-dependent manner and ...
... Biologic Activity Data Reviewed in End of Phase 2a Meeting ... Pharmaceuticals, Inc. (Nasdaq: VIAP ), a biotechnology company ... cardiovascular and metabolic disease, announced today that an end of ... was recently held with the U.S. Food and Drug Administration ...
Cached Medicine Technology:Proteolix, Inc. Drug Candidate, PR-957, Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome 2Proteolix, Inc. Drug Candidate, PR-957, Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome 3VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 2VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 3VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 5
(Date:4/18/2014)... group of scientists from the University of Kentucky ... Aging has found interesting new information in a ... disease (PD). , Published in the journal ... cognitive function in depressed and non-depressed patients with ... used to treat motor symptoms of Parkinson,s disease ...
(Date:4/18/2014)... Johns Hopkins University School of Medicine researchers have been ... for diabetes, Novo Nordisk announced this month. Of the ... and Obesity Biologics Science Forum Program, only four projects ... Hopkins researchers. They are Jonathan Powell, M.D., Ph.D.; G. ... , Jonathan Powell, a professor of oncology, will use ...
(Date:4/18/2014)... Calif. (April 18, 2014) ― A new study in ... weekly patterns in health-related Google searches reveals a recurring ... strategies. , Investigators from San Diego State ... the Monday Campaigns, analyzed "healthy" Google searches (searches that ... "healthy diet") originating in the U.S. from 2005 to ...
(Date:4/17/2014)... Men who show signs of chronic inflammation in non-cancerous ... actually having prostate cancer than those with no inflammation, ... researchers from the Johns Hopkins Kimmel Cancer Center. , ... stronger for men with so-called high-grade prostate cancer ... indicating the presence of the most aggressive and ...
(Date:4/17/2014)... published today in PLOS Pathogens , children who ... common can mount an immune response to infection with ... bouts of high fever and illness and partially control ... findings may help researchers develop future interventions that prevent ... , Each year, approximately 200 million cases of malaria ...
Breaking Medicine News(10 mins):Health News:Treating depression in PD patients: New research 2Health News:New research shows people are thinking about their health early in the week 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2
... BROOK, Ill., July 7 The University HealthSystem,Consortium (UHC), ... of Chief Learning Officer. Dr. Pingleton has more than ... to UHC from The,University of Kansas School of Medicine ... Chair of Internal Medicine. From 2007-2008, Dr.,Pingleton was the ...
... commonly associated with Type 2 diabetes also have much greater ... to research to be presented today (Tuesday 8 July 2008). ... key collaborator on an international study which will today be ... The study found that women who were overweight or had ...
... pressure, studies show , , MONDAY, July 7 (HealthDay News) -- ... and vegetable cooking oils appear to help prevent heart attacks, ... keep blood pressure low, two international research teams report. , ... omega-3 fatty acids reduced the risk of heart attack by ...
... most trusted and,accessible health care providers, pharmacists play ... more than 80 million recommendations to their,patients every ... In fact, a recent survey, conducted by Harris ... Education, found that,most Americans (80%) would purchase a ...
... fight to protect Pennsylvania families ... from inadequate regulations, ... and advocates for the elderly and the disabled is pushing,for ... The Pennsylvania Assisted Living Consumer Alliance (PALCA) formed this,year to ...
... Alterations in a molecular brain pathway activated by marijuana ... to a report in the July issue of ... journals. , Expression of the cannabinoid 1 receptor (CB1R), ... of marijuana, is significantly reduced in the brains of ...
Cached Medicine News:Health News:University HealthSystem Consortium Names Susan K. Pingleton, MD, as Its Chief Learning Officer 2Health News:Omega-3, Some Omega-6 Fatty Acids Boost Cardiovascular Health 2Health News:Omega-3, Some Omega-6 Fatty Acids Boost Cardiovascular Health 3Health News:New Coalition Presses for Quality Standards for Assisted Living Facilities in PA 2Health News:New Coalition Presses for Quality Standards for Assisted Living Facilities in PA 3Health News:New Coalition Presses for Quality Standards for Assisted Living Facilities in PA 4Health News:Schizophrenia linked to dysfunction in molecular brain pathway activated by marijuana 2
Pipetman 8X200 Multichannel Pipette is an eight-channel, fully adjustable, air-displacement pipette having a useful volume range from 20 L to 200 L. Robustwith the usual Gilson qualities this pipette...
Inquire...
... is precision, ergonomics, and value! , ... soft non-slip, contoured handle , Finer control ... action , Stress-free tip ejection with long, ... easy decontamination and sterilization without the need ...
... Lightest Pipettor , , The Shortyavailable with ... of how our face-to-face relationship with the scientific ... that make pipetting easier and more effective., ... pipettors., Gets you closer to the working ...
Medicine Products: